| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-21 | 0.04 | (7.98) | (0.14)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-22 | 0.67 | (12.99) | (11.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-23 | 0.63 | (10.83) | (0.06)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-24 | 0.72 | (9.89) | (5.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-25 | n/a | (22.18) | (12.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Director Dealings | 07-Jan-2026 | 07:00 | RNS |
| TR-1: Notification of major holdings | 07-Jan-2026 | 07:00 | RNS |
| Director Dealings | 05-Jan-2026 | 07:00 | RNS |
| Convertible Loan Note Conversion | 02-Jan-2026 | ShareCast |
| Tungsten West losses widen as Hemerdon work cont... | 24-Dec-2025 | ShareCast |
| Exercise of Options & TVR | 23-Dec-2025 | ShareCast |
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 31-Dec-25 | Buy | Richard William Macfarlane Maxey | 3.00p | 366,210 | £10,986.30 |
| 31-Dec-25 | Buy | Phil Povey | 3.00p | 2,995,305 | £89,859.15 |
| Currency | UK Pounds |
| Share Price | 11.00p |
| Change Today | -0.50p |
| % Change | -4.35 % |
| 52 Week High | 12.00 |
| 52 Week Low | 11.00 |
| Volume | 5,900,100 |
| Shares Issued | 775.22m |
| Market Cap | £85.27m |
| Value |
|
|---|
| Value |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 17:06 | 200,000 @ 11.00p |
| 16:42 | 4,290,001 @ 11.50p |
| 16:35 | 307,500 @ 11.00p |
| 16:35 | 4,000 @ 11.00p |
| 16:35 | 3,500 @ 11.00p |
You are here: research